KAZIA THERAPEUTICS LTD's ticker is KZIA and the CUSIP is 48669G105. A total of 9 filers reported holding KAZIA THERAPEUTICS LTD in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5 | -16.7% | 5 | 0.0% | 0.00% | – |
| Q2 2023 | $6 | +20.0% | 5 | 0.0% | 0.00% | – |
| Q1 2023 | $5 | +66.7% | 5 | 0.0% | 0.00% | – |
| Q4 2022 | $3 | – | 5 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 5 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 5 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 5 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | – | 5 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | – | 5 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | – | 5 | 0.0% | 0.00% | – |
| Q1 2021 | $0 | – | 5 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 5 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 5 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 5 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 5 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | – | 5 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | – | 5 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 5 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | – | 5 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | – | 5 | 0.0% | 0.00% | – |
| Q3 2018 | $0 | – | 5 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | – | 5 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | – | 5 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | – | 5 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HighPoint Advisor Group LLC | 32,435 | $96,000 | 0.02% |
| Transform Wealth, LLC | 106,245 | $41,000 | 0.01% |
| UBS Group AG | 100 | $0 | 0.00% |
| Renaissance Technologies | 34,325 | $129,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 5 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| BREWIN DOLPHIN LTD | 32 | $120 | 0.00% |
| MORGAN STANLEY | 67,003 | $251,000 | 0.00% |
| AdvisorNet Financial, Inc | 5 | $0 | 0.00% |
| Citadel Advisors | 12,803 | $49,000 | 0.00% |